Cumulative incidence estimates of the probability of disease-free survival according to phase of disease at transplantation. Patients alive without relapse beyond 10 years (at 13.5 and 17.0 years) and 1 patient who received a transplant in CR 2/3 alive without relapse beyond 10 years (at 11.6 years) are indicated as censored observations at 10 years.